Overall rank by patents
#26,866
Across all tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 10 technology areas, active 2021–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G06T (IMAGE DATA PROCESSING OR GENERATION, IN GENERAL).
The verdict
Maxar holds 10 US patents across 10 technology areas, rank #26,866 of 50,000 tracked assignees.
Maxar Intelligence Inc. has been granted 10 US utility patents between 2021 and 2024, placing Maxar Intelligence Inc. at rank #26,866 across all assignees tracked by PlainPatent. This portfolio spans 10 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.2 claims per patent with primary concentration in G06T (IMAGE DATA PROCESSING OR GENERATION, IN GENERAL). As a US Corporation, Maxar Intelligence Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Maxar sits between Matrix Industries, Inc. (10 patents, rank #26,862) and Medisynergics, Llc (10 patents, rank #26,870) - the closest US assignees by grant volume. The composite Innovation Score of 51.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2021 through 2024, with 10 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Maxar Intelligence Inc.'s 19.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 10 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Maxar Intelligence Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Matrix Industries, Inc.
10 patents
MatrixCare, Inc.
10 patents
MavorCo Operations LLC
10 patents
Max-Delbrück-Centrum Für Molekulare Medizin (MDC) Berlin-Buch
10 patents
Maxout Renewable, Inc.
10 patents
Measurement Specialties (Chengdu) Ltd
10 patents
MedHab, LLC
10 patents
MediSynergics, LLC
10 patents
Maxar Intelligence Inc.
10 patents
What this shows Maxar holds 10 patents at rank #26,866, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #26,866 in granted patent volume.
Other assignees with the most granted patents in Maxar's primary technology class.
Maxar's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
51 Top 12% higher than 88% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 1 | 10.0% |
| 2022 | 5 | 50.0% |
| 2023 | 1 | 10.0% |
| 2024 | 3 | 30.0% |
Top 10 of 10 technology areas
Overall rank by patents
#26,866
Across all tracked assignees
51.0 out of 100
How to use this portfolio
Maxar's 10 grants land it in the top 12% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.